Upcoming IPOs This Week (July 8-12) – Get Ready to Invest

Here are the upcoming initial public offerings (IPOs) for the week of July 8-12, according to TipRanks’ IPO calendar. An IPO refers to the public debut of a private company. After the IPO, the company’s shares become available for trading (selling/buying) on ​​an exchange.

There are several advantages and disadvantages to taking a company public. These advantages include the ability to raise capital, greater liquidity, and improved brand recognition. On the other hand, a publicly traded company is subject to strict financial reporting standards, is constantly in the spotlight and accountable to shareholders, and incurs high costs associated with maintaining compliance with regulatory requirements.

The IPO market is gaining traction this year, with challenges like high inflation and interest rates showing signs of moderating. Against this backdrop, let’s take a look at this week’s upcoming IPOs.

OS Therapies Inc.

OS Therapies is a clinical-stage biopharmaceutical company focused on the identification and development of drug candidates for the treatment of osteosarcoma (OS) and other solid tumors. The company currently has six drugs in its pipeline in various stages of clinical studies.

OS Therapies intends to issue 2 million shares of its common stock on July 10 at a price of $4 per share. The stock is expected to list on the NYSE under the symbol “OSTX.”

The Company expects to raise $7.84 million in net proceeds (taking into account the full over-allotment by the underwriters) from the offering. OS Therapies will use approximately $4.2 million of the proceeds for the clinical development of its osteosarcoma drug, OST-HER2. An additional $1.2 million will be used for the development of OST-tADC for ovarian cancer. The remaining funds will be used for the identification of novel drug candidates and general corporate purposes.

Primega Group Holdings Ltd

Primega Group Holdings operates through its Hong Kong-based subsidiary, Primega Construction Engineering Co. Ltd. The company specializes in soil and rock processing. Primega’s main businesses include environmental protection transportation, construction works and the sale of high-quality biodiesel approved for construction contractors.

Primega is offering a total of 1.75 million shares in its initial public offering, of which 1.50 million are new shares and 0.25 million are offered by the selling shareholder. Primega is expected to list its common stock on the Nasdaq Capital Market on July 12, under the ticker symbol “PGHL.” The new share offering is priced at a range of $4.00 to $6.00 per share. The new share offering will represent 6.25% of the Company’s outstanding shares, while the selling shareholders’ interest will represent 1% of the Company’s outstanding shares.

Primega expects to raise net proceeds of $4.55 million (after deducting underwriting discounts and expenses) from the offering, at a midpoint of $5 per share. Approximately 35% of the proceeds will be used to expand the existing business, 20% to modernize information technology systems and the remainder to cover working capital needs.

Disclosure